Ambroxol

• Description:

  Ambroxol is indicated as "secretolytic therapy in bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  378.1

• Molecular Formula:

  C13H18Br2N2O

• Notes:

  Research use only, not for human use.

• Receptor:

  CYP3A

• CAS Number:

  18683-91-5